Current heart attack therapeutics only address symptoms and cannot restore heart function.
- Over 1 Million heart attacks in the U.S. each year
- 659,000 deaths per year killing more annually than all forms of cancer combined
- One billion heart cells are lost after a heart attack
- There has been no way to regenerate new heart tissue as all current drugs only provide symptomatic relief
- Congestive Heart Failure Drugs alone are forecasted to reach $18.1 billion by 2027 with the heart failure device market projected to reach $20.5 billion by 2030
Future therapies will reverse damage caused following a heart attack
